New Strong Buy Stocks for November 2nd

Five companies were added to the Zacks Rank #1 (Strong Buy) list, with current-year earnings consensus estimates rising over the prior 60 days: YPF 36.5%, Petrobras 24.5%, Bausch + Lomb 17.5%, Littelfuse 16.4% and Vertiv 6.8%. The article also promotes a report naming seven stocks tied to quantum computing, but provides no stock names or quantified market outlook for the technology.

Analysis

The useful signal is estimate-revision breadth, not the “Strong Buy” label: revisions can support near-term momentum, but without the underlying earnings bridge, valuation, and prior guidance it is not evidence that earnings power has structurally improved. Treat the quantum-computing promotion as unrelated marketing, not a catalyst for the named companies.

Over 1–3 months, the clearest potential read-through is infrastructure spending: Vertiv and Littelfuse may benefit if hyperscaler and data-center investment converts into orders, while a slowdown or delayed projects could unwind the same expectation premium. Verify orders/backlog, book-to-bill, and customer capex commentary; estimate revisions that lack corresponding operating evidence are vulnerable to reversal. Bausch + Lomb offers a different, healthcare-driven earnings path, but confirm whether revisions reflect durable volume/mix or one-off assumptions.

YPF and Petroleo Brasileiro have exposure to policy and commodity outcomes as well as company execution. For YPF, Argentina’s regulatory, currency, and domestic pricing regime can outweigh operating progress; for Petroleo Brasileiro, state influence and capital-allocation decisions can dominate oil-price sensitivity. These are not clean substitutes for U.S. infrastructure growth exposure. Over 6–18 months, the key distinction is whether revisions become delivered cash flow rather than simply higher forecasts. No valuation or price data are supplied, so the ranking alone does not establish attractive entry levels.

Key Decisions for Investors

• Avoid buying the five names as a basket solely on the ranking. Before adding, compare each revision with the latest reported results, guidance, and valuation; the article supplies none of those checks.
• Watchlist trade: consider a staged long in Vertiv or Littelfuse only after confirming order/backlog and customer-capex support in company updates. Falsify the thesis if order trends weaken, guidance is cut, or estimate revisions turn negative; no price-based entry is justified by the supplied data.
• Keep YPF and Petroleo Brasileiro as separate, event-driven energy exposures rather than treating upward estimates as a sector signal. Reassess around material policy, fiscal, or capital-allocation developments and changes in oil prices.
• For Bausch + Lomb, wait for reported results to validate the earnings revisions; monitor organic growth and guidance. If estimates rise without improving operating delivery, treat the signal as a potential reversal rather than a buy catalyst.
• Ignore the quantum-computing pitch for these names absent verifiable contracts, revenue contribution, or disclosed investment plans; it provides no actionable linkage to the estimate-revision story.